Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER: Dexpramipexole in ALS
NCT01281189Phase 3Completed
- Sponsor
- Knopp Biosciences
- Start
- Mar 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of dexpramipexole in amyotrophic lateral sclerosis (ALS), sponsored by Knopp Biosciences. Started Mar 2011; status: completed.
02
Drugs
dexpramipexole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01281189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281189.